Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Knowledge on the safety of taking non-steroidal anti-inflammatory drugs
while pregnant is limited. In a population based study Nielsen et al
(p 266) investigated a possible association between take up of
prescriptions for these drugs and adverse birth outcome in a cohort of
1462 women. They also assessed the risks of non-steroidal anti-inflammatory drugs in a case-control study that compared 4268 cases of miscarriage with 29 750 primiparous controls who had live
births. They found no increased risk of adverse birth outcome in women
who took up prescriptions for non-steroidal anti-inflammatory drugs,
but there was a strong positive association with miscarriage.